The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?
Open accessAbstract
Abstract: Despite the fact that nonmotor symptoms (NMS) like gastrointestinal (GI) complaints are frequently reported in Parkinson’s disease (PD), no therapeutic guidelines are available. This study aimed to manage some lower GI-NMS in a group of patients with PD. A total of 40 patients (17 males, 23 females; mean age 76.05±2.09 years) were randomly selected for this study. Patients were confirmed to have PD (modified Hoehn–Yars scale: 2.075±0.4) who had undergone levodopa or dopamine agonist treatment. In the non-motor symptoms questionnaire (NMS-Quest), regarding GI complaints, the following were recorded: abdominal pain, bloating, and constipation of mild-to-moderate severity. Laboratory studies, abdominal ultrasound, and upper and lower digestive endoscopies were performed to rule out organic issues. All patients increased their water intake to 2 L/d and alimentary fiber to 20–25 g/d. Twenty patients received trimebutine 200 mg three times daily half an hour before meals. The other 20 patients received probiotics (60 mg per-tablet of two lactic bacteria: Lactobacillus acidophilus and Bifidobacterium infantis ), 2×/d, 1 hour after meals for 3 months along with the reassessment of GI complaints. Our results demonstrated that there were significant statistical differences in all assessed symptoms in the first group: 1.55±0.51 vs 0.6±0.5 ( P <0.0001) for abdominal pain; 1.6±0.5 vs 0.45±0.51 ( P <0.0001) for bloating; and 1.5±0.51 vs 0.85±0.67 ( P =0.0014) for constipation with incomplete defecation. The second group displayed statistical differences only for abdominal pain 1.45±0.51 vs 1.05±0.69 ( P =0.00432) and bloating 1.4±0.5 vs 0.3±0.47 ( P <0.0001). For constipation with incomplete defecation, there was a slight improvement. Thus, there was no significant statistical difference: 1.35±0.49 vs 1.15±0.49 ( P =0.2040). In conclusion, lower GI-NMS are frequently present, isolated or associated with other autonomic issues, even before the diagnosis of PD. Treatment with probiotics could improve abdominal pain and bloating as much as with trimebutine, but less for constipation with incomplete evacuation, where trimebutine showed better results. Keywords: PD, lower GI-NMS, probiotics, prokinetics, trimebutine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies have shown that Lactobacillus acidophilus and Bifidobacterium infantis can improve abdominal pain and bloating in PD patients [40]”
From Neuroprotective Effect of Ceftriaxone on MPTP‐Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota (2021) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Goetz, C. G., Poewe, W. H., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C. E., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,360
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, К. R., & Schapira, A. H. V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,818
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445
What contributes to quality of life in patients with Parkinson's disease?
Schrag, A. E. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.3.308 · Cited by 1,420
Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839
Brain-Gut-Microbiota Axis in Parkinson’s Disease
Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583
Martínez‐Martín, P., Schapira, A. H. V., Stocchi, F., Sethi, K. D., Odin, P., Macphee, G. J. A., Brown, R. G., Naidu, Y., Clayton, L. M. S., Abe, K., et al. (2007) · Movement Disorders · doi:10.1002/mds.21586 · Cited by 556
Cersosimo, M. G., Raina, G. B., Pecci, C., Pellene, A., Calandra, C. R., Gutiérrez, C., Micheli, F. E., & Benarroch, E. E. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6801-2 · Cited by 314
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–138 of 138
Naureen, Z., Farooq, S., Zahoor, T., & Gilani, S. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-1626-6_19 · Cited by 6
Lactobacillaceae and Parkinson's disease: An apparent paradox
van der Maden, M. M., Verbeek, M. M., & Beckers, M. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x241312401 · Cited by 5
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review
Carrossa, G., Misenti, V., Faggin, S., Giron, M. C., & Antonini, A. (2025) · Biomedicines · doi:10.3390/biomedicines13071769 · Cited by 4
Al-Okbi, S., Mabrok, H., Al-Siedy, E. S. K., Mohamed, R., & Ramadan, A. (2021) · Journal of HerbMed Pharmacology · doi:10.34172/jhp.2022.07 · Cited by 2
El‐Mansoury, B., Smimih, K., Khiat, A. E., Fatimi, H. E., Aimrane, A., Baz, S. E., Elmourid, A., Saad, F. E.-Z., Ghachi, H. E., Khanouchi, M., et al. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5156-4.ch017 · Cited by 4
Kanda, A., Mazumder, A., Das, S., & Prabhakar, V. (2023) · Journal of Natural Remedies · doi:10.18311/jnr/2023/33944 · Cited by 4
The role of probiotics on slowing down the aging process
Şanlibaba, P., Toprak, Z. T., & Tezel, B. U. (2022) · Acta Scientiarum Polonorum Technologia Alimentaria · doi:10.17306/j.afs.1013 · Cited by 4
Therapeutic role of probiotics in motor and non-motor symptoms of Parkinson’s disease
Páez‐García, S., Hernández-Triana, D., Salazar, F. E., Barreto, G. E., Rodríguez-Oroz, M. C., & Borda, M. G. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.1004129 · Cited by 3
Lakshmi, B. A., Buddolla, V., Gubbiyappa, K. S., Suneetha, M., & Kim, Y. J. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111636 · Cited by 3
Psychobiotics in Health, Longevity, and Neurological Disorders
Mohankumar, A., Kalaiselvi, D., Thiruppathi, G., Patteswari, D., Tawata, S., & Sundararaj, P. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-8158-5_2 · Cited by 3
Animal Models Used for Studying the Benefits of Probiotics in Neurodegeneration
Divyashri, G., & Prapulla, S. G. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_10 · Cited by 3
Dietary interventions in Parkinson’s disease: An update
Pavan, S., Prabhu, A., Gorthi, S. P., Shetty, V., Rajesh, V., Hegde, A., & Ballal, M. (2022) · Biomedicine · doi:10.51248/.v42i3.1639 · Cited by 3
Santos, R. B., dos Anjos, H. A., Ribeiro, T. T., & Correia, V. D. D. M. R. (2020) · Research Society and Development · doi:10.33448/rsd-v9i9.7259 · Cited by 2
Al‐Okbi, S. Y., Ramadan, A., Mohamed, R. S., Mabrok, H. B., & Al-Siedy, E. S. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-08740-6 · Cited by 2
Cabanillas-Lazo, M., Pascual-Guevara, M., Chavez‐Ecos, F. A., Alva-Diaz, C., Velásquez‐Rimachi, V., Mori, N., & Micheli, F. E. (2026) · Gerontology · doi:10.1159/000547665 · Cited by 2
Idosos com doença de parkinson: perfil e condições de saúder
Baptista, R. D. C., Álvarez, Á. M., Nunes, S. F. L., Valcarenghi, R. V., & Barbosa, S. D. F. F. (2020) · Enfermagem em Foco · doi:10.21675/2357-707x.2019.v10.n5.2604 · Cited by 2
Psychobiotics as an Emerging Category of Probiotic Products
Choudhary, S., Shanu, K., & Devi, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-1463-0_19 · Cited by 3
Yang, X., He, X., Xu, S., Zhang, Y., Mo, C., Lai, Y., Song, Y., Zheng, Y., Ai, P., Qian, Y., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4087361 · Cited by 2
Psychobiotics and Elderly Health
DÜDÜKÇÜ, N., & Öğüt, S. (2022) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1033628 · Cited by 1
How gut microbes affect Parkinson’s disease: an editorial
Nasir, R., Haseeb, A., Mustafa, M. S., Mussarat, A., Ali, L., Shafique, M. A., & Ahmed, K. A. H. M. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003098 · Cited by 1
Gut microbiota in regulation of neuromuscular coordination
Roy, S., Chakraborty, B., & Choudhury, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33351-4.00024-6 · Cited by 1
Devi, S., Debnath, N., Yadav, P., Satyavolu, S., Yadav, A. K., & Tyagi, N. (2026) · Comprehensive physiology · doi:10.1002/cph4.70165 · Cited by 1
Abdominal pain in Parkinson’s disease
Pilipovich, A. A., Vorobyova, O. V., & Makarov, S. A. (2023) · Russian Journal of Pain · doi:10.17116/pain20232102112 · Cited by 1
Interplay Between Gut-microbiota and Neurodegeneration
Ashique, S., Pal, R., Kumar, S., Verma, B., Kumar, N., Kahwa, I., Farid, A., Mishra, N., Kumar, P., & Taghizadeh‐Hesary, F. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010009 · Cited by 1
The role of probiotics on slowing down the aging process [pdf]
Şanlıbaba, P., Toprak, Z. T., & TEZEL, B. U. (2022) · Acta Scientiarum Polonorum Technologia Alimentaria · doi:10.17306/j.afs.2022.1013
Ghalandari, N., Assarzadegan, F., Mahdavi, H., Jamshidi, E., & Esmaily, H. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4199878
Park, J. M., Lee, S. C., Ham, C., & Kim, Y. W. (2023) · Research Square · doi:10.21203/rs.3.rs-2461162/v1
Role of probiotics in brain health
Thakur, A. K., Shekhar, N., Tyagi, S., & Rani, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18951-7.00009-8
Research Progress of Gut Microbiota on Parkinson’s Disease
袁, 薇. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141154
Exploring the Interplay Between Gut Microflora and Parkinson’s
Swathi, M., Hazra, A., Dhanu, A. S., & Basalingappa, K. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_15
Introduction to Gut Microbiota and their Effects on Various Brain Disorders
Usmani, A., & Mishra, A. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010008
Role of microbiota-gut-brain axis on neurotransmitter modulation
Anitha, K., Bhatt, S., Chikatipalli, R., & Ravula, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00016-x
Park, J. M., Lee, S. C., Ham, C., & Kim, Y. W. (2024) · Figshare · doi:10.6084/m9.figshare.26573137
Park, J. M., Lee, S. C., Ham, C., & Kim, Y. W. (2024) · Figshare · doi:10.6084/m9.figshare.26573134
Park, J. M., Lee, S. C., Ham, C., & Kim, Y. W. (2024) · Figshare · doi:10.6084/m9.figshare.26573140
The Gut-Brain Axis in Parkinson’s Disease: Probiotic Interventions and Mechanistic Insights
Hasnain, M. A., Bashir, H. H., & Moon, G. (2025) · Current Topic in Lactic Acid Bacteria and Probiotics · doi:10.35732/ctlabp.2025.11.2.41
Microbiome and Diseases: Gut–Brain Axis and Neurological Disorders
de Castilhos, J., & Stein‐Thoeringer, C. K. (2026) · Springer eBooks · doi:10.1007/978-3-032-26410-7_18
The role of gut microbiota in Parkinson's disease pharmacotherapy
Wadan, A. S., Hammadeh, B. M., Ahmed, M. A., Maged, A. A., & Ellakwa, D. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-54032-5.00002-4
Metadata
- Authors
- Georgescu, D., Ancusa, O., Georgescu, L., Ionita, I., & Reisz, D.
- Affiliations
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
- Corresponding author
- Ancusa, Oana
- Venue
- Clinical Interventions in Aging
- Publisher
- Informa UK Limited
- Published
- 2016-11
- Volume
- Volume 11
- Pages
- 1601-1608
- ISSN
- 1176-9092 (ISSN-L)
- 1178-1998
- PMC
- PMC5113937
- OpenAlex
- W2550869378
- Cited by
- 138
- References
- 29
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 29 · 2023: 21 · 2022: 34 · 2021: 20 · 2020: 5 · 2019: 4 · 2018: 1 · 2017: 1
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical Interventions in Aging (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, non-motor symptoms, gastrointestinal symptoms, constipation, abdominal pain, bloating, trimebutine, probiotics, Lactobacillus acidophilus, Bifidobacterium infantis, dietary fiber, older adults, levodopa, dopamine agonists, symptom management, quality of life, activities of daily living
- MeSH terms
- Age Factors, Aged, Bifidobacterium, Female, Gastrointestinal Agents, Gastrointestinal Diseases, Humans, Lactobacillus acidophilus, Male, Parkinson Disease, Trimebutine, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
